The Journal
Unlocking the
aesthetics arena.
The studies that move the field. The regulation you'll need to act on. The claims that don't survive scrutiny. Concise, referenced, written for working clinicians.
Earlier pieces
Clinical
29 July 2026
Rosacea Barrier Recovery After Aesthetic Treatment: The Protocol Your Clients Need
In rosacea skin, the barrier is already compromised before any treatment begins. IPL, chemical peels and laser each create an additional disruption. What the recovery window looks like, and how to manage it.
Business
29 July 2026
Lifetime Patient Value in Aesthetic Practice: The Number Most Practitioners Have Never Calculated
Most aesthetic practitioners know what each appointment earns. Very few know what a patient relationship is worth over three or four years. That number changes every business decision in a practice.
Treatments
28 July 2026
Hormonal Melasma: Triggers, Presentation and Clinical Management
Hormonal melasma is driven by oestrogen. OCP, HRT and perimenopause are the key clinical triggers. What UK aesthetic practitioners need to know and document.
Ingredient science
23 July 2026
Tranexamic Acid for Hyperpigmentation: What the Evidence Shows
Topical tranexamic acid is one of the best-evidenced agents for melasma and PIH. Here is what the clinical literature shows for UK aesthetic practitioners.
Clinical
22 July 2026
Demodex Folliculorum and Rosacea: What UK Aesthetic Practitioners Need to Know
Elevated Demodex density is a consistent finding in papulopustular rosacea. Practitioners who understand the evidence can assess more accurately, refer more confidently, and support better long-term outcomes.
Clinical
22 July 2026
Acne After Antibiotics: Microbiome Considerations for UK Aesthetic Practitioners
Many patients arrive at aesthetic practice after extended antibiotic courses that have not resolved their acne. Here is what the microbiome evidence tells us about how to proceed.
Ingredient science
21 July 2026
Polynucleotide Injectables in Aesthetic Practice: What the Evidence Shows
Polynucleotide injectables are widely used in UK aesthetic practice. A 2025 systematic review of nine trials clarifies what the published evidence shows.
Regulation
16 July 2026
Consent in Aesthetic Practice: What GMC and NMC Require in 2026
Informed consent in UK aesthetic practice is governed by GMC, NMC, and JCCP requirements. What valid consent looks like, and what your records must show.
Clinical
15 July 2026
Melasma in Aesthetic Practice: Differential Diagnosis and the UK Evidence Base
Melasma is the most commonly mismanaged pigmentation presentation in UK aesthetic practice. Accurate differential diagnosis changes everything about the treatment plan.
Clinical
15 July 2026
Hormonal Acne in Adult Women: Recognising the Pattern and Adapting Your Treatment Plan
Adult female acne follows a hormonal pattern that teenage acne does not. UK aesthetic practitioners who recognise the difference will see better outcomes and fewer treatment plateaus.
Regulation
14 July 2026
Red, Amber and Green: England's Aesthetics Licensing Tiers
England's aesthetics licensing sorts treatments into Red, Amber and Green risk tiers. What each tier means, which treatments are where, and what it requires.
Regulation
12 July 2026
Aesthetic Practitioner Scope of Practice: 2026 UK Guide
Scope of practice in UK aesthetics is governed by registration, competence, and treatment classification. What the NMC, GMC, and licensing scheme require.
Regulation
9 July 2026
Remote Prescribing in Aesthetic Practice: The 2025 UK Rules
UK regulators banned remote prescribing for cosmetic POMs in 2025. NMC, GMC and JCCP all require face-to-face assessment before botulinum toxin is prescribed.
Business
8 July 2026
Building Consistent Monthly Income in Aesthetic Practice: Getting the Structure Right in 2026
Unpredictable monthly income is the most common financial complaint I hear from aesthetic practitioners. It is rarely a demand problem. It is almost always a structure problem.
Clinical
8 July 2026
Antibiotic Stewardship in Acne: What UK Aesthetic Practitioners Need to Know in 2026
NICE guidance on acne and antibiotic resistance is explicit. Many aesthetic practitioners are not following it. Here is what the evidence requires, and what it means for how you prescribe and advise.
Regulation
7 July 2026
NMC Revalidation for Aesthetic Nurses: The 2026 Guide
NMC revalidation requires 450 practice hours, 35 CPD hours and five reflective accounts every three years. What nurses in aesthetic practice need to prepare.
Regulation
5 July 2026
Record Keeping in Aesthetic Practice: UK Requirements 2026
UK law, UK GDPR, the NMC Code, and JCCP standards all shape medical record keeping in aesthetic practice. What every UK practitioner must know for 2026.
Regulation
2 July 2026
CQC Registration for Aesthetic Practices: When It Applies
CQC registration and aesthetic licensing are separate requirements. Here is when aesthetic practices in England need to register with the Care Quality Commission.
Clinical
1 July 2026
Rosacea Subtype Classification: The Assessment That Shapes Every Treatment Decision
Accurate rosacea subtype classification at consultation is the decision that determines the whole treatment plan. Here is how to do it correctly in aesthetic practice.
Clinical
1 July 2026
Post-Inflammatory Hyperpigmentation Treatment: Building a Protocol That Works
PIH treatment stalls when the protocol is not built to match the client's skin type, the depth of the pigment, and the underlying trigger. The assessment comes first.
Regulation
1 July 2026
England Aesthetics Licensing: What Has Changed in July 2026
England's aesthetics licensing rollout reaches July 2026. Here is what has changed today, what is still being staged, and what practitioners should do this month.
Regulation
30 June 2026
Do You Need a Level 7 Qualification to Practise Aesthetics?
A Level 7 qualification is not yet a universal legal requirement to practise aesthetics in the UK, but it is the standard the regulation is moving toward.
Regulation
30 June 2026
Professional Indemnity for Aesthetic Practitioners: 2026
Professional indemnity insurance is required under JCCP standards and the forthcoming aesthetic licensing scheme. Here is what adequate cover means in practice.
Regulation
28 June 2026
Botox and Fillers for Under-18s: What the 2021 Act Requires
It has been a criminal offence to give cosmetic botox or fillers to under-18s in England since 2021. What the Act covers and what age verification requires.
Regulation
25 June 2026
JCCP Standards for Aesthetic Practitioners: What to Have in Place
The JCCP framework sets the professional standards behind England's aesthetic licensing scheme. What practitioners need to know, maintain and evidence.
Clinical
24 June 2026
The Hyperpigmentation Consultation: A Clinical Framework for Aesthetic Practitioners
Hyperpigmentation is not a single condition. Getting the consultation right means knowing which type you are treating before you choose any active ingredient or procedure.
Clinical
24 June 2026
Building an Acne Treatment Plan: What UK Aesthetic Practitioners Need to Know
An acne treatment plan is only as good as the assessment behind it. Here is the clinical framework UK aesthetic practitioners should be working from, based on NICE NG198 and current evidence.
Regulation
23 June 2026
Remote Prescribing in Aesthetics: What the 2025 Rules Require
From 1 June 2025, nurse prescribers cannot remotely prescribe injectable cosmetics. What NMC, GMC and GPhC guidance now requires in aesthetic practice.
Regulation
21 June 2026
Informed Consent for Aesthetic Treatments: What UK Law Requires
Informed consent for aesthetic treatments is a two-stage process. What JCCP standards and UK regulators require practitioners to document and get right.
Regulation
18 June 2026
Advertising Injectables in the UK: ASA and MHRA Rules Explained
UK practitioners cannot advertise botulinum toxin to the public. Here is what ASA and MHRA rules actually prohibit, and what your clinic can say instead.
Clinical
17 June 2026
Rosacea and Barrier Function: The Clinical Link Practitioners Miss
Barrier dysfunction is central to rosacea pathophysiology, not an afterthought. Understanding it changes treatment sequencing, skincare recommendations, and why some clients never hold their results.
Regulation
17 June 2026
NMC Revalidation for Aesthetic Nurses: Getting CPD Right
NMC revalidation requires 35 hours of CPD every three years. Here is what counts for aesthetic nurses, what the common recording gaps are, and how to build a portfolio that holds up.
Ingredient science
16 June 2026
Niacinamide in Aesthetic Practice: The Clinical Evidence
Niacinamide is among the most-studied topical actives in aesthetic practice. What peer-reviewed evidence supports for hyperpigmentation, acne, and skin barrier.
Ingredient science
14 June 2026
Polynucleotide Injectables: What the Evidence Shows in 2026
Polynucleotide injectables are the most-discussed regenerative treatment in UK aesthetics. What the evidence actually supports, and what it does not.
Business
10 June 2026
Aesthetics Business Income in the UK: What Practitioners Are Actually Earning in 2026
Most aesthetic practitioners are earning less than their skills and training should command. The income gap is structural, not clinical. Here is what it looks like and how practitioners are closing it.
Clinical
10 June 2026
The Acne Microbiome: What UK Aesthetic Practitioners Need to Know
Acne is not a single-organism disease. Understanding microbial diversity, strain differences, and treatment interactions changes how you approach acne assessment in aesthetic practice.
Ingredient science
9 June 2026
Topical Peptides in Aesthetic Practice: What the Evidence Shows
Topical peptides are among the most evidence-referenced ingredients in aesthetic skincare. What the clinical evidence shows, and what practitioners need to assess.
Ingredient science
4 June 2026
Topical Vitamin C in Aesthetics: What the Evidence Shows
Topical vitamin C has more peer-reviewed evidence behind it than most active ingredients in aesthetic skincare. Here is what the literature actually supports.
Regulation
4 June 2026
What aesthetic practitioners in England need to have done before July 2026
The licensing deadline is weeks away. This is the practical checklist: what documentation you need, what gaps are most commonly found, and where to start if you haven't started.
Ingredient science
3 June 2026
Tranexamic Acid for Melasma: The 2026 Evidence Review
Tranexamic acid for melasma has the strongest evidence base of any oral depigmenting option. What the meta-analyses show, and what UK practitioners must know.
Regulation
3 June 2026
Exosomes in Aesthetics: What the Evidence and Regulators Say
Exosomes are the most-marketed product in aesthetics right now. What the clinical evidence actually supports, and where UK and FDA regulators draw the line.
Treatments
28 May 2026
Glycolic Acid Peels in UK Aesthetic Practice: The Evidence
Glycolic acid peels are among the best-evidenced superficial procedures in UK aesthetic practice. What the evidence shows for acne, PIH, and photoaging.
Ingredient science
26 May 2026
Topical Vitamin C in Aesthetic Practice: The Clinical Evidence
Topical vitamin C is among the best-evidenced cosmeceuticals in UK aesthetic practice. What peer-reviewed literature supports, and where formulation makes the difference.
Regulation
24 May 2026
NMC Prescribing Standards for Cosmetic Injectables 2025
From June 2025, NMC registrants must consult face-to-face before prescribing cosmetic injectables. Here is what changed and what compliance requires.
Ingredient science
21 May 2026
Retinoids in UK Aesthetic Practice: The Clinical Evidence
Topical retinoids in UK aesthetic practice: what the peer-reviewed evidence supports, where the prescribing boundary sits, and how to apply them clinically.
Treatments
12 May 2026
Rosacea Treatment in Aesthetic Practice: 2026 Evidence
Rosacea treatment for UK aesthetic practitioners: what each subtype responds to, where the evidence base sits, and where scope of practice begins and ends.
Ingredient science
10 May 2026
Azelaic Acid for UK Practitioners: The Full Clinical Picture
Azelaic acid is licensed for rosacea and acne in the UK. Here is what the evidence supports across all three indications and what practitioners need to know.
Ingredient science
3 May 2026
PIH vs PIE: why your acne client's marks aren't fading
If your acne client's marks aren't fading after the spots clear, the issue isn't acne anymore. It's whether you're treating PIH or PIE.
Regulation
2 May 2026
England's aesthetic licensing scheme: what's coming, and how to be ready before it lands
England's statutory licensing scheme for non-surgical cosmetic procedures is the biggest regulatory shift UK aesthetics has seen. Here is what the legislation says, what the consultation has signalled, and what practitioners should be doing now.
Treatments
30 April 2026
Vascular Occlusion in Hyaluronic Acid Filler: UK Practitioner Protocol
Vascular occlusion hyaluronic acid filler UK: recognition, hyaluronidase protocol, prescribing duties and the documentation a defensible practitioner needs.
Studies
30 April 2026
NICE Acne Guidelines (NG198) for Aesthetic Practitioners
NICE acne guidelines NG198: severity bands, first-line treatments, referral pathways, and what aesthetic practitioners can and can't do under the framework.
Regulation
30 April 2026
MHRA Rules on Promoting Botox in the UK: What Practitioners Can Say
MHRA Botox advertising UK: the POM advertising prohibition, the MHRA Blue Guide, the CAP Code, and what a UK practitioner can actually put online.
Treatments
28 April 2026
Vascular occlusion: the recognition window every injector needs to own
Vascular occlusion is the complication every injector trains for and hopes never to see. When it happens, the first ninety minutes decide whether the client keeps her tissue.
Treatments
28 April 2026
Microneedling Evidence in 2026: What UK Practitioners Should Know
Microneedling in 2026: where the peer-reviewed evidence actually sits, where it is still thin, and what UK practitioners need to know.
Editorial
27 April 2026
Why this exists. What you'll get from it.
The studies that matter. The regulation that's changing. The claims that don't survive a primary source, for working clinicians.
New here?
Join free. No subscription.
Put your name down, it is completely free, no subscription and no card. You get a login by email, first sight of new courses, and offers when they run.